| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.33 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Introdução: A diabetes mellitus tipo 2 (DM2) é uma doença metabólica crónica que se correlaciona com o estilo de vida e que é habitualmente seguida pelos Médicos de Família nos cuidados de saúde primários. O surgimento da pandemia por SarsCov-2 trouxe uma mudança tanto dos hábitos e do estilo de vida dos portugueses como da prestação dos cuidados de saúde por parte das USF/UCSP. Desta forma, o principal objetivo deste trabalho é avaliar o impacto da pandemia no controlo glicémico dos doentes com DM2 seguidos na USF Villa Longa. Métodos: Estudo observacional longitudinal nos utentes com diagnóstico de DM2 seguidos na USF Villa Longa. Para tal, comparou-se os valores de HbA1c de uma amostra desta população em períodos homólogos pré e após início de pandemia, Março de 2020. A análise comparativa fez-se recorrendo a estatística T de amostras emparelhadas. Resultados: Verificou-se uma redução do número de utentes com medição de HbA1c após o início da pandemia. Não se verifica, na amostra total de utentes analisada, diferença significativa da Δ HbA1c no período após o início da pandemia. A análise de subgrupos demonstra uma redução do crescimento dos valores de HbA1c de 0.10% (p=0.02) no grupo de doentes com HbA1c basal < 7%. O subgrupo de doentes com HbA1c basal ≥ 8% manteve a tendência decrescente observada antes do início da pandemia (redução de 0.84%), porém, após a pandemia, esta tendência foi menor (redução de 0.34%) (p=0.04). Discussão: Os diabéticos da USF Villa Longa que mantiveram seguimento durante a pandemia não apresentaram, de forma geral, importante Δ HbA1c. Contudo, desconhece-se o controlo glicémico pós-pandemia de muitos dos diabéticos desta USF, uma vez que houve redução do número de análises de HbA1c realizadas nesse período.
Introduction: Type 2 diabetes mellitus (DM2) is a chronic metabolic disease that correlates with lifestyle and medical follow-up is usually take in Primary healthcare. The SarsCov-2 pandemic brought changes in Portuguese people lifestyle and in healthcare. The main objective of this work is to assess the impact of the pandemic on the glycemic control of patients with DM2 followed at the USF Villa Longa. Methods: Longitudinal observational study in patients diagnosed with DM2 followed at the USF Villa Longa. For this purpose, the HbA1c values of a sample of this population were compared in homologous periods before and after the start of the pandemic in March 2020. The comparative analysis was carried out using a paired sample T-test. Results: There was a reduction in the number of diabetics with HbA1c measurement after the start of the pandemic. There is no significant difference in the Δ HbA1c in the total sample of diabetics analyzed in the period after the beginning of the pandemic. Subgroup analysis shows a reduction in the growth of HbA1c values of 0.10% (p = 0.02) in the group of patients with baseline HbA1c <7%. The subgroup of patients with baseline HbA1c ≥ 8% maintained the decreasing trend observed before the start of the pandemic (reduction of 0.84%), however, after the pandemic, this trend was smaller (reduction of 0.34%) (p = 0.04). Discussion: The diabetics at the USF Villa Longa who were followed up during the pandemic did not present, in general, an important Δ HbA1c. However, the postpandemic glycemic control of many of the diabetics in this USF is unknown, since there was a reduction in the number of HbA1c analyzes performed in that period.
Introduction: Type 2 diabetes mellitus (DM2) is a chronic metabolic disease that correlates with lifestyle and medical follow-up is usually take in Primary healthcare. The SarsCov-2 pandemic brought changes in Portuguese people lifestyle and in healthcare. The main objective of this work is to assess the impact of the pandemic on the glycemic control of patients with DM2 followed at the USF Villa Longa. Methods: Longitudinal observational study in patients diagnosed with DM2 followed at the USF Villa Longa. For this purpose, the HbA1c values of a sample of this population were compared in homologous periods before and after the start of the pandemic in March 2020. The comparative analysis was carried out using a paired sample T-test. Results: There was a reduction in the number of diabetics with HbA1c measurement after the start of the pandemic. There is no significant difference in the Δ HbA1c in the total sample of diabetics analyzed in the period after the beginning of the pandemic. Subgroup analysis shows a reduction in the growth of HbA1c values of 0.10% (p = 0.02) in the group of patients with baseline HbA1c <7%. The subgroup of patients with baseline HbA1c ≥ 8% maintained the decreasing trend observed before the start of the pandemic (reduction of 0.84%), however, after the pandemic, this trend was smaller (reduction of 0.34%) (p = 0.04). Discussion: The diabetics at the USF Villa Longa who were followed up during the pandemic did not present, in general, an important Δ HbA1c. However, the postpandemic glycemic control of many of the diabetics in this USF is unknown, since there was a reduction in the number of HbA1c analyzes performed in that period.
Description
Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2021
Keywords
SARS-CoV-2 Diabetes mellitus tipo 2 Hemoglobina A glicada (HbA1c) Pandemia